Search Results 1131-1140 of 18472 for Immunode
History of human immunodeficiency virus with acquired immunodeficiency syndrome at Screening. Active bacterial or fungal infection that is clinically ...
Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for this ...
History of human immunodeficiency virus (HIV) infection or positive HIV Type 1 (HIV-1)/HIV Type 2 (HIV-2) serology or positive HIV deoxyribonucleic acid ...
Known human immunodeficiency virus, active hepatitis B, active hepatitis C, or active mycobacterium tuberculosis infection. If female, the patient is ...
Inclusion Criteria: Subject or legally authorized representative provides written authorization and/or consent per institution and geographical requirements ...
Human immunodeficiency virus (HIV)-associated PAH, schistosomiasis associated PAH, PAH associated with portal hypertension, or pulmonary veno-occlusive disease ...
toxicity. 13. Participant has untreated, known human immunodeficiency virus (HIV), hepatitis B virus (HBV), or hepatitis C virus (HCV). In addition ...
Known human immunodeficiency virus infection. Presence of hepatitis B surface antigen (HbsAg) or hepatitis B core antibody (anti-HbcAb), at Screening or ...
The purpose of this study is to evaluate the safety and effectiveness of the BCL2 inhibitor BGB-11417 in participants with relapsed/refractory Waldenström's ...
Positive test for hepatitis B, C or HIV (Human Immunodeficiency Virus) virus; Previous treatment with checkpoint inhibitor drugs; Active CNS metastases or ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.